Genetic Mutations and Family History
705 articles
Helene Andrews-Polymenis, Ph.D., D.V.M.
A native of the Pacific Northwest, Dr. Helene Andrews-Polymenis earned an A.B. in Biology from Brown University (1989), Ph.D. in Molecular Biology/Microbiology from Tufts University (1999), and a D.V.M. from Texas A&M University (TAMU) in 2001. After completing her postdoctoral training, Dr. Andrews-Polymenis joined the faculty in the Department of Microbial and Molecular Pathogenesis at […]
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
Combining Two Drugs with Different Approaches to Enhance Treatment
A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.
Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer
A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.
More Research Needed for Pancreatic Cancer Immunotherapy
Dr. Luis Diaz provides a status check for immunotherapy treatments for pancreatic cancer, including an explanation of different types.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.